NCT07763691

Brief Summary

The goal of this clinical trial is to learn whether robot-assisted mirror therapy improves upper extremity function in children with spastic hemiparetic cerebral palsy. The study will also compare the effects of robot-assisted mirror therapy with those of conventional mirror therapy. The main questions this study aims to answer are:

  • Does robot-assisted mirror therapy improve spasticity, grip strength, selective motor control, hand skills, bimanual performance, participation in activities of daily living, and quality of life?
  • Does robot-assisted mirror therapy improve upper extremity function more than conventional mirror therapy? Researchers will compare robot-assisted mirror therapy combined with neurodevelopmental treatment with conventional mirror therapy combined with neurodevelopmental treatment. Participants will:
  • Receive individualized neurodevelopmental treatment for 6 weeks.
  • Complete a 2-week interval after neurodevelopmental treatment.
  • Be randomly assigned to either the robot-assisted mirror therapy group or the conventional mirror therapy group.
  • Receive robot-assisted mirror therapy or conventional mirror therapy twice a week for 6 weeks.
  • Complete assessments before neurodevelopmental treatment, after neurodevelopmental treatment, before the study intervention, and after the intervention. Researchers will evaluate upper extremity function, spasticity, grip strength, selective motor control, hand skills, bimanual performance, participation in activities of daily living, and quality of life using standardized clinical assessment tools.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
1mo left

Started Mar 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress92%
Mar 2025Sep 2026

Study Start

First participant enrolled

March 25, 2025

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

August 10, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 13, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2026

Last Updated

August 13, 2026

Status Verified

August 1, 2026

Enrollment Period

1.5 years

First QC Date

August 10, 2026

Last Update Submit

August 10, 2026

Conditions

Keywords

Hemiplegic Cerebral PalsyCerebral PalsyMirror TherapyRobotic-Assisted Mirror TherapyRehabilitationVisual FeedbackWearable RoboticsSpastic Hemiparesis

Outcome Measures

Primary Outcomes (2)

  • Change in Self-Perceived Occupational Performance as Measured by the Canadian Occupational Performance Measure (COPM)

    The Canadian Occupational Performance Measure (COPM) is a client-centered measure of occupational performance in self-care, productivity, and leisure. Children identify important activities they want, need, or are expected to perform but find difficult and rate their performance on a 10-point scale; higher scores indicate better performance. The mean performance score is the sum of the ratings divided by the number of activities. Changes in the mean performance score will be calculated for the relevant assessment periods by subtracting the baseline score from the Week 6 score and the Week 8 score from the Week 14 score. Positive change scores indicate improved self-perceived occupational performance. In the present study, the COPM will be used to assess children's occupational performance in daily life activities they identify as important.

    Baseline; end of Week 6 (after the NDT period); end of Week 8 (immediately before the combined intervention: NDT+RAT or NDT+MT); and end of Week 14 (immediately after the 6-week combined intervention: NDT+RAT or NDT+MT)

  • Change in Self-Perceived Satisfaction With Occupational Performance as Measured by the Canadian Occupational Performance Measure (COPM)

    The Canadian Occupational Performance Measure (COPM) is a client-centered measure of satisfaction with occupational performance in self-care, productivity, and leisure. Children identify important activities they want, need, or are expected to perform but find difficult and rate their satisfaction with their performance on a 10-point scale; higher scores indicate greater satisfaction. The mean satisfaction score is the sum of the ratings divided by the number of activities. Changes in the mean satisfaction score will be calculated for the relevant assessment periods by subtracting the baseline score from the Week 6 score and the Week 8 score from the Week 14 score. Positive change scores indicate increased satisfaction with occupational performance. In the present study, the COPM will be used to assess children's satisfaction with their performance in daily life activities they identify as important.

    Baseline; end of Week 6 (after the NDT period); end of Week 8 (immediately before the combined intervention: NDT+RAT or NDT+MT); and end of Week 14 (immediately after the 6-week combined intervention: NDT+RAT or NDT+MT)

Secondary Outcomes (13)

  • Change in Wrist Flexor Spasticity as Assessed by the Modified Ashworth Scale (MAS)

    Baseline; end of Week 6 (after the NDT period); end of Week 8 (immediately before the combined intervention: NDT+RAT or NDT+MT); and end of Week 14 (immediately after the 6-week combined intervention: NDT+RAT or NDT+MT)

  • Change in Wrist Extensor Spasticity as Assessed by the Modified Ashworth Scale (MAS)

    Baseline; end of Week 6 (after the NDT period); end of Week 8 (immediately before the combined intervention: NDT+RAT or NDT+MT); and end of Week 14 (immediately after the 6-week combined intervention: NDT+RAT or NDT+MT)

  • Change in Forearm Pronator Spasticity as Assessed by the Modified Ashworth Scale (MAS)

    Baseline; end of Week 6 (after the NDT period); end of Week 8 (immediately before the combined intervention: NDT+RAT or NDT+MT); and end of Week 14 (immediately after the 6-week combined intervention: NDT+RAT or NDT+MT)

  • Change in Forearm Supinator Spasticity as Assessed by the Modified Ashworth Scale (MAS)

    Baseline; end of Week 6 (after the NDT period); end of Week 8 (immediately before the combined intervention: NDT+RAT or NDT+MT); and end of Week 14 (immediately after the 6-week combined intervention: NDT+RAT or NDT+MT)

  • Change in Selective Motor Control of the Affected Upper Extremity as Measured by the Total Selective Control of the Upper Extremity Scale (SCUES) Score

    Baseline; end of Week 6 (after the NDT period); end of Week 8 (immediately before the combined intervention: NDT+RAT or NDT+MT); and end of Week 14 (immediately after the 6-week combined intervention: NDT+RAT or NDT+MT)

  • +8 more secondary outcomes

Study Arms (2)

Robot-Assisted Mirror Therapy (RAT)

EXPERIMENTAL

All participants will first undergo baseline assessment and receive neurodevelopmental treatment (NDT). After the NDT period, participants will be reassessed and randomized. Participants allocated to this arm will receive robot-assisted mirror therapy in addition to NDT twice weekly for 6 weeks. Each session will include 40 minutes of NDT and 30 minutes of robotic intervention. Participants will perform the planned exercises with the unaffected upper extremity positioned in front of the therapy mirror (Metafiz, Turkey), while the hemiparetic upper extremity will be positioned behind the mirror inside a robotic glove (FosilTech, Turkey). The commercially available robotic glove uses a mechanism similar to that of devices previously shown feasible for pediatric rehabilitation. During the intervention, it will provide passive symmetrical movements to the affected upper extremity corresponding to the exercises performed by the unaffected upper extremity in front of the mirror.

Device: Robot-Assisted Mirror TherapyBehavioral: Neurodevelopmental Treatment

Mirror Therapy (MT)

ACTIVE COMPARATOR

All participants will undergo baseline assessment and receive neurodevelopmental treatment (NDT). After completion of the NDT period, participants will be reassessed and randomized. Participants assigned to this arm will receive a combined intervention consisting of NDT and conventional mirror therapy twice weekly for 6 weeks. Each session will include 40 minutes of NDT followed by 30 minutes of mirror therapy. During mirror therapy, participants will perform the planned exercises with the unaffected upper extremity positioned in front of the therapy mirror (Metafiz, Turkey), while the affected upper extremity will be positioned behind the mirror. No intervention will be applied directly to the affected upper extremity during mirror therapy. Participants will observe the mirror reflection of the unaffected upper-extremity movements, thereby creating the visual illusion that the affected upper extremity is performing the movements.

Behavioral: Mirror TherapyBehavioral: Neurodevelopmental Treatment

Interventions

Participants will receive robot-assisted mirror therapy in addition to neurodevelopmental treatment. The unaffected hand will perform movements in front of a mirror, while the affected hand will be positioned behind it inside a pneumatic robotic glove (FosilTech, Turkey). The glove operates through air compression and vacuum. For each movement, the air valves controlling the fingers will be set open or closed. Open valves permit airflow and passive finger movement, whereas closed valves restrict airflow and stop selected fingers. The valve configuration will be adjusted to create a hand position symmetrical to that of the unaffected hand. The motor will be operated via remote control in synchrony and coordination with the unaffected-hand movements, producing corresponding passive movements of the affected hand and providing mirrored visual feedback and bilateral movement training. Robot-assisted mirror therapy will be administered for 30 minutes per session, twice weekly for 6 weeks.

Robot-Assisted Mirror Therapy (RAT)
Mirror TherapyBEHAVIORAL

Participants will receive conventional mirror therapy in addition to neurodevelopmental treatment. A mirror is positioned in the participant's midsagittal plane to create the visual illusion that the affected upper extremity is moving normally while performing bilateral upper extremity exercises. Mirror therapy will be administered for 30 minutes per session, twice weekly for 6 weeks.

Mirror Therapy (MT)

Participants will receive a neurodevelopmental treatment (NDT) program administered by a physiotherapist. The intervention will focus on facilitating normal movement patterns, postural control, balance, and upper extremity function through task-oriented therapeutic activities. NDT will be administered for 40 minutes per session, twice weekly for 6 weeks.

Mirror Therapy (MT)Robot-Assisted Mirror Therapy (RAT)

Eligibility Criteria

Age6 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children classified within levels I, II, or III of the Communication Function Classification System (CFCS) Medical records indicating a diagnosis of prenatal, intrapartum, or very early postnatal hemiparetic cerebral palsy, confirmed by neurologists and supported by magnetic resonance imaging (MRI).
  • Being between 6-17 years of age Being able to cooperate Attending age-appropriate classes Ability to extend the wrist by more than 20 degrees and the metacarpophalangeal joints by more than 10 degrees Ability to voluntarily release objects with the affected hand

You may not qualify if:

  • Diagnosis of intellectual disability and/or low cognitive level suitable for attending a special education school, Behavioral and adaptation difficulties observed in the child during the administration of study assessments.
  • Diagnosis of attention deficit and/or hyperactivity disorder History of epileptic seizures Upper extremity fracture, muscle-tendon or bone surgery within the past six months, or use of any pharmacological agents to inhibit spasticity, including botulinum toxin administration Uncorrected hearing and/or visual impairment Severe muscle tone in the shoulder, elbow, or wrist, indicated by a Modified Ashworth Scale score greater than 3.
  • Any new treatment planned during the study period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dilbade Özel Eğitim ve Rehabilitasyon Merkezi

Istanbul, 34050, Turkey (Türkiye)

Location

Related Publications (25)

  • Jackman M, Sakzewski L, Morgan C, Boyd RN, Brennan SE, Langdon K, Toovey RAM, Greaves S, Thorley M, Novak I. Interventions to improve physical function for children and young people with cerebral palsy: international clinical practice guideline. Dev Med Child Neurol. 2022 May;64(5):536-549. doi: 10.1111/dmcn.15055. Epub 2021 Sep 21.

    PMID: 34549424BACKGROUND
  • Goyal C, Vardhan V, Naqvi W. Virtual Reality-Based Intervention for Enhancing Upper Extremity Function in Children With Hemiplegic Cerebral Palsy: A Literature Review. Cureus. 2022 Jan 28;14(1):e21693. doi: 10.7759/cureus.21693. eCollection 2022 Jan.

    PMID: 35237486BACKGROUND
  • Kara OK, Yardimci BN, Sahin S, Orhan C, Livanelioglu A, Soylu AR. Combined Effects of Mirror Therapy and Exercises on the Upper Extremities in Children with Unilateral Cerebral Palsy: A Randomized Controlled Trial. Dev Neurorehabil. 2020 May;23(4):253-264. doi: 10.1080/17518423.2019.1662853. Epub 2019 Sep 13.

    PMID: 31514564BACKGROUND
  • Najiha A, Alagesan J. Mirror therapy : A review of evidences. International Journal of Physiotherapy and Research. 2015, 3(3):1086-90.

    BACKGROUND
  • Stevens JA, Stoykov ME. Using motor imagery in the rehabilitation of hemiparesis. Arch Phys Med Rehabil. 2003 Jul;84(7):1090-2. doi: 10.1016/s0003-9993(03)00042-x.

    PMID: 12881842BACKGROUND
  • Kim DH, Lee KD, Bulea TC, Park HS. Increasing motor cortex activation during grasping via novel robotic mirror hand therapy: a pilot fNIRS study. J Neuroeng Rehabil. 2022 Jan 24;19(1):8. doi: 10.1186/s12984-022-00988-7.

    PMID: 35073933BACKGROUND
  • Bruchez R, Jequier Gygax M, Roches S, Fluss J, Jacquier D, Ballabeni P, Grunt S, Newman CJ. Mirror therapy in children with hemiparesis: a randomized observer-blinded trial. Dev Med Child Neurol. 2016 Sep;58(9):970-8. doi: 10.1111/dmcn.13117. Epub 2016 Apr 5.

    PMID: 27046296BACKGROUND
  • Gygax MJ, Schneider P, Newman CJ. Mirror therapy in children with hemiplegia: a pilot study. Dev Med Child Neurol. 2011 May;53(5):473-6. doi: 10.1111/j.1469-8749.2011.03924.x. Epub 2011 Mar 17.

    PMID: 21410693BACKGROUND
  • Palomo-Carrion R, Zuil-Escobar JC, Cabrera-Guerra M, Barreda-Martinez P, Martinez-Cepa CB. [Mirror and action observation therapy in children with unilateral spastic cerebral palsy: a feasibility study]. Rev Neurol. 2022 Dec 1;75(11):325-332. doi: 10.33588/rn.7511.2022343. Spanish.

    PMID: 36440744BACKGROUND
  • Farzamfar, P.; Heirani, A.; Sedighi, M. The effect of motor training in mirror therapy on gross motor skills of the affected hand in children with hemiplegia. Iran. Rehabil. J. 2017, 15, 243-248.

    BACKGROUND
  • Ortega-Martinez A, Palomo-Carrion R, Varela-Ferro C, Bagur-Calafat MC. Feasibility of a Home-Based Mirror Therapy Program in Children with Unilateral Spastic Cerebral Palsy. Healthcare (Basel). 2023 Jun 19;11(12):1797. doi: 10.3390/healthcare11121797.

    PMID: 37372915BACKGROUND
  • Park EJ, Baek SH, Park S. Systematic review of the effects of mirror therapy in children with cerebral palsy. J Phys Ther Sci. 2016 Nov;28(11):3227-3231. doi: 10.1589/jpts.28.3227. Epub 2016 Nov 29.

    PMID: 27942154BACKGROUND
  • Nam HS, Koh S, Beom J, Kim YJ, Park JW, Koh ES, Chung SG, Kim S. Recovery of Proprioception in the Upper Extremity by Robotic Mirror Therapy: a Clinical Pilot Study for Proof of Concept. J Korean Med Sci. 2017 Oct;32(10):1568-1575. doi: 10.3346/jkms.2017.32.10.1568.

    PMID: 28875598BACKGROUND
  • Schrader M, Sterr A, Kettlitz R, Wohlmeiner A, Buschfort R, Dohle C, Bamborschke S. The effect of mirror therapy can be improved by simultaneous robotic assistance. Restor Neurol Neurosci. 2022;40(3):185-194. doi: 10.3233/RNN-221263.

    PMID: 35848045BACKGROUND
  • Lieber J, Dittli J, Lambercy O, Gassert R, Meyer-Heim A, van Hedel HJA. Clinical utility of a pediatric hand exoskeleton: identifying users, practicability, and acceptance, and recommendations for design improvement. J Neuroeng Rehabil. 2022 Feb 11;19(1):17. doi: 10.1186/s12984-022-00994-9.

    PMID: 35148786BACKGROUND
  • Carnahan KD, Arner M, Hagglund G. Association between gross motor function (GMFCS) and manual ability (MACS) in children with cerebral palsy. A population-based study of 359 children. BMC Musculoskelet Disord. 2007 Jun 21;8:50. doi: 10.1186/1471-2474-8-50.

    PMID: 17584944BACKGROUND
  • Smyth RE, Theurer J, Archibald LM, Oram Cardy J. Lessons learned in practice-based research: Studying language interventions for young children in the real world. Autism Dev Lang Impair. 2020 Apr 3;5:2396941520913482. doi: 10.1177/2396941520913482. eCollection 2020 Jan-Dec.

    PMID: 36440323BACKGROUND
  • Vaillant E, Oostrom KJ, Beckerman H, Vermeulen JR, Buizer AI, Geytenbeek JJM. Convergent validity of functional communication tools and spoken language comprehension assessment in children with cerebral palsy. Int J Lang Commun Disord. 2022 Sep;57(5):963-976. doi: 10.1111/1460-6984.12732. Epub 2022 May 30.

    PMID: 35637603BACKGROUND
  • Özek M.M. Spastisite ve Tedavisi Murat Başarır. Türk Nöroşirürji Dergisi. 2013, 23;2, 158-173.

    BACKGROUND
  • Tunçdemir M, Spastik Serebral Palsili Çocuklarda Selektif Motor Kontrolün Değerlendirilmesi ve Aktivite, Katılım ve Sağlıkla İlgili Yaşam Kalitesi Üzerine Etkisinin İncelenmesi. H.Ü. Sağlık Bilimleri Enstitüsü, YüksekLisansTezi, s.48-24 Ankara, 2019.

    BACKGROUND
  • Wagner LV, Davids JR, Hardin JW. Selective Control of the Upper Extremity Scale: validation of a clinical assessment tool for children with hemiplegic cerebral palsy. Dev Med Child Neurol. 2016 Jun;58(6):612-7. doi: 10.1111/dmcn.12949. Epub 2015 Nov 3.

    PMID: 26526592BACKGROUND
  • Allgower K, Hermsdorfer J. Fine motor skills predict performance in the Jebsen Taylor Hand Function Test after stroke. Clin Neurophysiol. 2017 Oct;128(10):1858-1871. doi: 10.1016/j.clinph.2017.07.408. Epub 2017 Jul 31.

    PMID: 28826016BACKGROUND
  • Eren M, Ekici G,Alkan H. Reliability and Validity of Turkish Version of Children's Hand Use Experience Questionnaire for Children With Hemiparetic Cerebsal Palsy. International Health Administration and Education (Sanitas Magisterium). 2021,7(1), 85-92.

    BACKGROUND
  • Erden A, Korkmaz N. Activity and Participation Measurement Tools Adapted to Turkish for the Pediatric Population: Traditional Review .Turkiye Klinikleri J Pediatr. 2022;31(2):121-32

    BACKGROUND
  • Tuncdemir M, Karakaya J, Kerem-Gunel M. Reliability and Validity of the Turkish Version of the Selective Control of the Upper Extremity Scale in Children with Cerebral Palsy. Phys Occup Ther Pediatr. 2022;42(1):99-112. doi: 10.1080/01942638.2021.1928809. Epub 2021 May 24.

    PMID: 34030602BACKGROUND

MeSH Terms

Conditions

Cerebral PalsyHemiplegia

Interventions

Mirror Movement Therapy

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Physical Therapy ModalitiesRehabilitationTherapeutics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: All participants initially receive neurodevelopmental treatment and are evaluated before and after this initial treatment period. Following this period, participants are randomized into two parallel groups. One group receives robot-assisted therapy in addition to neurodevelopmental treatment, while the other group receives mirror therapy in addition to neurodevelopmental treatment. This design allows the effects of the initial neurodevelopmental treatment period to be evaluated, as well as the effects of the two subsequent treatment approaches to be compared.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physiotherapist, PhD Candidate

Study Record Dates

First Submitted

August 10, 2026

First Posted

August 13, 2026

Study Start

March 25, 2025

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

September 30, 2026

Last Updated

August 13, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will share

De-identified individual participant data collected during the study, including demographic data, baseline characteristics, intervention-related data, outcome measures, and follow-up assessments, will be made available after completion of the primary study analyses and publication of the main study results in an international peer-reviewed journal. A data dictionary and relevant study documentation necessary for data interpretation will also be provided.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Beginning upon publication of the primary study results in an international peer-reviewed journal and continuing for 5 years.
Access Criteria
Following publication of the primary study results in an international peer-reviewed journal, de-identified individual participant data, the study protocol, data dictionary, statistical analysis plan and informed consent form will be available to qualified researchers who submit a methodologically sound research proposal. Data will be shared upon reasonable request to the principal investigator and may require a data use agreement.

Locations